• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用扩散加权磁共振成像对口咽鳞状细胞癌受累淋巴结放疗的每周反应评估

Weekly response assessment of involved lymph nodes to radiotherapy using diffusion-weighted MRI in oropharynx squamous cell carcinoma.

作者信息

Tyagi Neelam, Riaz Nadeem, Hunt Margie, Wengler Kenneth, Hatzoglou Vaios, Young Robert, Mechalakos James, Lee Nancy

机构信息

Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, New York 10065.

Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, New York 10065.

出版信息

Med Phys. 2016 Jan;43(1):137. doi: 10.1118/1.4937791.

DOI:10.1118/1.4937791
PMID:26745906
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5360161/
Abstract

PURPOSE

Patients with cancers of oropharynx have a favorable prognosis and are an ideal candidate for adaptive therapy. A replan to improve coverage or escalate/de-escalate dose based on morphological information alone may not be adequate as the grossly involved lymph nodes (LNs) of a subset of these patients tend to become cystic and often do not regress. Functional adaptation may be a better approach when considering replanning for these patients. The purpose of this study was to evaluate the weekly trends in treatment related morphological and physiological changes for these LNs using diffusion-weighted MRI (DW-MRI) and evaluate its implications for adaptive replanning.

METHODS

Ten patients with histologically proven oropharynx HNSCC undergoing concurrent chemoradiation were analyzed in this study. MR imaging protocol included axial T1w, T2w, and DW-MRI using a 3 T Philips MR scanner. The patients were scanned weekly in radiation treatment planning position using a 16 element phased-array anterior coil and a 44 element posterior coil. A total of 65 DWI and T2w scans were analyzed. DWI was performed using an optimized single-shot echo planar imaging sequence (TR/TE = 5000/65 ms, slice thickness = 5 mm; slices = 28; b values = 0 and 800 s/mm(2)). Quantification of the DW-MRI images was performed by calculating the apparent diffusion coefficient (ADC). T2w and DWI scans were imported into the Eclipse treatment planning system and gross tumor volumes (GTVs) corresponding to grossly involved LNs were contoured on each axial slice by physician experts. An attempt was made to remove any cystic or necrotic components so that the ADC analysis was of viable tumor only. A pixel-by-pixel fit of signal intensities within the GTVs was performed assuming monoexponential behavior. From each GTV histogram mean, median, standard deviation, skewness, and kurtosis were calculated. Absolute and percent change in weekly ADC histogram parameters and percent change in T2w GTV were also calculated.

RESULTS

For all nodes, an immediate change in ADC was observed during first 2-3 weeks after which ADC values either continued to increase or plateaued. A few nodal volumes had a slightly decreased ADC value during later weeks. Percent increase in median ADC from weeks 1 to 6 with respect to baseline was 14%, 25%, 41%, 42%, 45%, and 58%. The corresponding change in median T2 volumes was 8%, 10%, 16%, 22%, 40%, and 42%, respectively. The ADC distribution of the viable tumors was initially highly kurtotic; however, the kurtosis decreased as treatment progressed. The ADC distribution also showed a higher degree of skewness in the first 2 weeks, progressively becoming less skewed as treatment progressed so as to slowly approach a more symmetric distribution.

CONCLUSIONS

Physiological changes in LNs represented by changes in ADC evaluated using DW-MRI are evident sooner than the morphological changes calculated from T2w MRI. The decisions for adaptive replanning may need to be individualized and should be based primarily on tumor functional information. The authors' data also suggest that for many patients, week 3 maybe the optimal time to intervene and replan. Larger studies are needed to confirm their findings.

摘要

目的

口咽癌患者预后良好,是适应性治疗的理想候选者。仅基于形态学信息重新规划以改善覆盖范围或增加/减少剂量可能并不充分,因为这些患者中的一部分其受累肿大淋巴结往往会变成囊性,且通常不会消退。在考虑为这些患者重新规划时,功能适应性可能是一种更好的方法。本研究的目的是使用扩散加权磁共振成像(DW-MRI)评估这些淋巴结与治疗相关的形态学和生理学变化的每周趋势,并评估其对适应性重新规划的影响。

方法

本研究分析了10例经组织学证实为口咽癌的头颈部鳞状细胞癌患者,这些患者正在接受同步放化疗。磁共振成像方案包括使用3T飞利浦磁共振扫描仪进行的轴位T1加权、T2加权和DW-MRI检查。患者每周在放射治疗计划体位下使用16元素相控阵前线圈和44元素后线圈进行扫描。共分析了65次DWI和T2加权扫描。DWI使用优化的单次激发回波平面成像序列(TR/TE = 5000/65 ms,层厚 = 5 mm;层数 = 28;b值 = 0和800 s/mm²)进行。通过计算表观扩散系数(ADC)对DW-MRI图像进行定量分析。将T2加权和DWI扫描图像导入Eclipse治疗计划系统,由医生专家在每个轴位切片上勾勒出与受累肿大淋巴结相对应的大体肿瘤体积(GTV)。试图去除任何囊性或坏死成分,以便ADC分析仅针对存活肿瘤。假设信号强度呈单指数行为,对GTV内的信号强度进行逐像素拟合。从每个GTV直方图中计算均值、中位数、标准差、偏度和峰度。还计算了每周ADC直方图参数的绝对变化和百分比变化以及T2加权GTV的百分比变化。

结果

对于所有淋巴结,在最初的2 - 3周内观察到ADC立即发生变化,此后ADC值要么继续增加,要么趋于平稳。在随后的几周内,少数淋巴结体积的ADC值略有下降。第1至6周相对于基线,ADC中位数的百分比增加分别为14%、25%、41%、42%、45%和58%。相应的T2体积中位数变化分别为8%、10%、16%、22%、40%和42%。存活肿瘤的ADC分布最初具有高度峰度;然而,随着治疗进展,峰度降低。ADC分布在最初2周也显示出较高程度的偏度,随着治疗进展逐渐变得不那么偏斜,从而缓慢接近更对称的分布。

结论

使用DW-MRI评估的以ADC变化表示的淋巴结生理学变化比从T2加权MRI计算的形态学变化更明显。适应性重新规划的决策可能需要个体化,并且应主要基于肿瘤功能信息。作者的数据还表明,对于许多患者,第3周可能是进行干预和重新规划的最佳时间。需要更大规模的研究来证实他们的发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97fb/5360161/47c3249b75ee/MPHYA6-000043-000137_1-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97fb/5360161/d735278bddd7/MPHYA6-000043-000137_1-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97fb/5360161/a030685fcb81/MPHYA6-000043-000137_1-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97fb/5360161/23c4f910799c/MPHYA6-000043-000137_1-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97fb/5360161/eb75299de177/MPHYA6-000043-000137_1-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97fb/5360161/98c385c452f8/MPHYA6-000043-000137_1-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97fb/5360161/469f088fa7cd/MPHYA6-000043-000137_1-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97fb/5360161/47c3249b75ee/MPHYA6-000043-000137_1-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97fb/5360161/d735278bddd7/MPHYA6-000043-000137_1-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97fb/5360161/a030685fcb81/MPHYA6-000043-000137_1-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97fb/5360161/23c4f910799c/MPHYA6-000043-000137_1-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97fb/5360161/eb75299de177/MPHYA6-000043-000137_1-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97fb/5360161/98c385c452f8/MPHYA6-000043-000137_1-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97fb/5360161/469f088fa7cd/MPHYA6-000043-000137_1-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97fb/5360161/47c3249b75ee/MPHYA6-000043-000137_1-g007.jpg

相似文献

1
Weekly response assessment of involved lymph nodes to radiotherapy using diffusion-weighted MRI in oropharynx squamous cell carcinoma.使用扩散加权磁共振成像对口咽鳞状细胞癌受累淋巴结放疗的每周反应评估
Med Phys. 2016 Jan;43(1):137. doi: 10.1118/1.4937791.
2
Diffusion-weighted MRI of the lung at 3T evaluated using echo-planar-based and single-shot turbo spin-echo-based acquisition techniques for radiotherapy applications.使用基于回波平面和基于单次激发快速自旋回波的采集技术,对3T磁共振成像下的肺部进行扩散加权成像,以用于放射治疗应用。
J Appl Clin Med Phys. 2019 Jan;20(1):284-292. doi: 10.1002/acm2.12493. Epub 2018 Nov 12.
3
Characterization of cervical lymph-nodes using a multi-parametric and multi-modal approach for an early prediction of tumor response to chemo-radiotherapy.采用多参数和多模态方法对颈部淋巴结进行特征分析,以早期预测肿瘤对放化疗的反应。
Phys Med. 2016 Dec;32(12):1672-1680. doi: 10.1016/j.ejmp.2016.09.003. Epub 2016 Sep 14.
4
Apparent diffusion coefficients in GEC ESTRO target volumes for image guided adaptive brachytherapy of locally advanced cervical cancer.局部晚期宫颈癌图像引导自适应近距离治疗中 GEC ESTRO 靶区的表观扩散系数。
Acta Oncol. 2010 Oct;49(7):978-83. doi: 10.3109/0284186X.2010.500619.
5
Head and neck squamous cell carcinoma: value of diffusion-weighted MR imaging for nodal staging.头颈部鳞状细胞癌:扩散加权磁共振成像在淋巴结分期中的价值。
Radiology. 2009 Apr;251(1):134-46. doi: 10.1148/radiol.2511080128. Epub 2009 Feb 27.
6
Histogram analysis parameters identify multiple associations between DWI and DCE MRI in head and neck squamous cell carcinoma.直方图分析参数确定了头颈鳞状细胞癌中弥散加权成像(DWI)与动态对比增强磁共振成像(DCE MRI)之间的多种关联。
Magn Reson Imaging. 2018 Jan;45:72-77. doi: 10.1016/j.mri.2017.09.015. Epub 2017 Sep 28.
7
Estimation of optimal b-value sets for obtaining apparent diffusion coefficient free from perfusion in non-small cell lung cancer.估计用于获取非小细胞肺癌中不受灌注影响的表观扩散系数的最佳b值集。
Phys Med Biol. 2015 Oct 21;60(20):7877-91. doi: 10.1088/0031-9155/60/20/7877. Epub 2015 Sep 25.
8
Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.扩散峰度成像与标准扩散成像在周围区前列腺癌检测及分级中的评估
Invest Radiol. 2015 Aug;50(8):483-9. doi: 10.1097/RLI.0000000000000155.
9
Utility of diffusion MRI characteristics of cervical lymph nodes as disease classifier between patients with head and neck squamous cell carcinoma and healthy volunteers.弥散磁共振成像在头颈部鳞癌患者和健康志愿者间作为颈部淋巴结疾病分类器的应用。
NMR Biomed. 2021 Nov;34(11):e4587. doi: 10.1002/nbm.4587. Epub 2021 Jul 8.
10
Squamous cell carcinoma of the oral cavity and oropharynx: what does the apparent diffusion coefficient tell us about its histology?口腔和口咽鳞状细胞癌:表观扩散系数能告诉我们关于其组织学的哪些信息?
Acta Radiol. 2016 Nov;57(11):1344-1351. doi: 10.1177/0284185115587734. Epub 2016 Jul 12.

引用本文的文献

1
Institution-level Patterns of Care for Early-stage Oropharynx Cancers in the United States.美国早期口咽癌的机构级护理模式。
Am J Clin Oncol. 2024 Nov 1;47(11):542-548. doi: 10.1097/COC.0000000000001125. Epub 2024 Jun 20.
2
Target Definition in MR-Guided Adaptive Radiotherapy for Head and Neck Cancer.头颈部癌磁共振引导自适应放射治疗中的靶区定义
Cancers (Basel). 2022 Jun 20;14(12):3027. doi: 10.3390/cancers14123027.
3
Early Response Prediction of Multiparametric Functional MRI and F-FDG-PET in Patients with Head and Neck Squamous Cell Carcinoma Treated with (Chemo)Radiation.

本文引用的文献

1
Combined pre-treatment MRI and 18F-FDG PET/CT parameters as prognostic biomarkers in patients with cervical cancer.联合预处理MRI和18F-FDG PET/CT参数作为宫颈癌患者的预后生物标志物
Eur J Radiol. 2014 Jul;83(7):1169-1176. doi: 10.1016/j.ejrad.2014.03.024. Epub 2014 Mar 30.
2
Toward adaptive radiotherapy for head and neck patients: Feasibility study on using CT-to-CBCT deformable registration for "dose of the day" calculations.迈向头颈部患者的自适应放射治疗:关于使用CT到CBCT可变形配准进行“当日剂量”计算的可行性研究。
Med Phys. 2014 Mar;41(3):031703. doi: 10.1118/1.4864240.
3
Molecular PET imaging for biology-guided adaptive radiotherapy of head and neck cancer.
多参数功能磁共振成像和F-FDG-PET对接受(化疗)放疗的头颈部鳞状细胞癌患者的早期反应预测
Cancers (Basel). 2022 Jan 3;14(1):216. doi: 10.3390/cancers14010216.
4
Practical Safety Considerations for Integration of Magnetic Resonance Imaging in Radiation Therapy.磁共振成像在放射治疗中的实际安全注意事项。
Pract Radiat Oncol. 2020 Nov-Dec;10(6):443-453. doi: 10.1016/j.prro.2020.07.008. Epub 2020 Aug 8.
5
Quantitative diffusion magnetic resonance imaging for prediction of human papillomavirus status in head and neck squamous-cell carcinoma: A systematic review and meta-analysis.定量扩散磁共振成像预测头颈部鳞状细胞癌中人乳头瘤病毒状态:一项系统评价和荟萃分析。
Neuroradiol J. 2019 Aug;32(4):232-240. doi: 10.1177/1971400919849808. Epub 2019 May 14.
6
Study of diffusion weighted MRI as a predictive biomarker of response during radiotherapy for high and ntermediate risk squamous cell cancer of the oropharynx: The MeRInO study.扩散加权磁共振成像作为口咽高中危鳞状细胞癌放疗反应预测生物标志物的研究:MeRInO研究
Clin Transl Radiat Oncol. 2017 Jan 10;2:13-18. doi: 10.1016/j.ctro.2016.12.003. eCollection 2017 Feb.
7
Functional MRI for Treatment Evaluation in Patients with Head and Neck Squamous Cell Carcinoma: A Review of the Literature from a Radiologist Perspective.头颈部鳞状细胞癌患者治疗评估的功能磁共振成像:放射科医生视角的文献综述
Curr Radiol Rep. 2018;6(1):2. doi: 10.1007/s40134-018-0262-z. Epub 2018 Jan 22.
8
Apparent diffusion coefficient histogram shape analysis for monitoring early response in patients with advanced cervical cancers undergoing concurrent chemo-radiotherapy.表观扩散系数直方图形状分析用于监测晚期宫颈癌同步放化疗患者的早期反应
Radiat Oncol. 2016 Oct 22;11(1):141. doi: 10.1186/s13014-016-0715-6.
9
Biological imaging in clinical oncology: radiation therapy based on functional imaging.临床肿瘤学中的生物成像:基于功能成像的放射治疗
Int J Clin Oncol. 2016 Aug;21(4):626-632. doi: 10.1007/s10147-016-1000-2. Epub 2016 Jul 6.
10
Advanced imaging techniques in the therapeutic response of transarterial chemoembolization for hepatocellular carcinoma.先进成像技术在肝细胞癌经动脉化疗栓塞治疗反应中的应用
World J Gastroenterol. 2016 May 28;22(20):4835-47. doi: 10.3748/wjg.v22.i20.4835.
基于分子 PET 成像的头颈部肿瘤生物指导自适应放疗。
Acta Oncol. 2013 Oct;52(7):1257-71. doi: 10.3109/0284186X.2013.812799. Epub 2013 Sep 5.
4
Clinical outcomes among patients with head and neck cancer treated by intensity-modulated radiotherapy with and without adaptive replanning.接受有或无自适应重新计划的调强放射治疗的头颈癌患者的临床结局
Head Neck. 2014 Nov;36(11):1541-6. doi: 10.1002/hed.23477. Epub 2014 Jan 22.
5
Comparing primary tumors and metastatic nodes in head and neck cancer using intravoxel incoherent motion imaging: a preliminary experience.使用体素内不相干运动成像比较头颈癌中的原发性肿瘤和转移淋巴结:初步经验。
J Comput Assist Tomogr. 2013 May-Jun;37(3):346-52. doi: 10.1097/RCT.0b013e318282d935.
6
Expected treatment dose construction and adaptive inverse planning optimization: implementation for offline head and neck cancer adaptive radiotherapy.预期治疗剂量构建和自适应逆规划优化:离线头颈部癌症自适应放疗的实施。
Med Phys. 2013 Feb;40(2):021719. doi: 10.1118/1.4788659.
7
Diffusion-weighted MR imaging in the head and neck.头部和颈部的弥散加权磁共振成像。
Radiology. 2012 Apr;263(1):19-32. doi: 10.1148/radiol.11101821.
8
Adaptive radiotherapy for head-and-neck cancer: initial clinical outcomes from a prospective trial.头颈部癌症的自适应放疗:前瞻性试验的初步临床结果。
Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):986-93. doi: 10.1016/j.ijrobp.2011.08.017. Epub 2011 Dec 2.
9
Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: an update of the Memorial Sloan-Kettering Cancer Center experience.调强放疗治疗口咽癌:纪念斯隆-凯特琳癌症中心经验更新。
Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):291-8. doi: 10.1016/j.ijrobp.2010.10.041. Epub 2010 Dec 16.
10
ADC histograms predict response to anti-angiogenic therapy in patients with recurrent high-grade glioma.ADC 直方图预测复发性高级别胶质瘤患者对抗血管生成治疗的反应。
Neuroradiology. 2011 Apr;53(4):291-302. doi: 10.1007/s00234-010-0808-0. Epub 2010 Dec 2.